Phillip A. Sharp, Director: Alnylam Pharmaceuticals ALNY Planned sale · Filed 25/01/23

Trade details

Type: Planned sale notice
Stock: Alnylam Pharmaceuticals ALNY
Person: Phillip A. SharpDirector
Planned sale date: 25/01/23
Filed: 25/01/23

$3.1M to be sold

Alnylam Pharmaceuticals trades, last 26 weeks

What else happened in Alnylam Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/12/24~25/02/22

Phillip A. Sharp's recent trades

Phillip A. SharpDirector
Planned sale10b5-1 planAlnylam Pharmaceuticals
Planned sale10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$3.4M
11,250 sh
$3.4M
Filed 25/05/30
Traded 25/05/30
Phillip A. SharpDirector
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$3.1M
11,250 sh
$3.1M
Filed 25/01/24
Traded 25/01/23
Phillip A. SharpDirector
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$2.1M
13,557 sh
$2.1M
Filed 24/03/01
Traded 24/02/29
Phillip A. SharpDirector
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$2M
13,005 sh
$2M
Filed 24/03/01
Traded 24/02/29
Phillip A. SharpDirector
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$292.8K
1,906 sh
$292.8K
Filed 24/03/01
Traded 24/02/29

Phillip A. Sharp, Director — plans to sell 11,250 sh of Alnylam Pharmaceuticals ALNY · $3.1M · around 01/23 · 10b5-1 plan | Whalegun